首頁 > 市場調查報告書 > 材料

包裝/容器

市場調查報告書

商品編碼

1410099

消毒帽市場：2023年至2028年預測

Disinfection Cap Market - Forecasts from 2023 to 2028

出版日期: 2023年12月11日 | 出版商:

Knowledge Sourcing Intelligence | 英文 142 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄

預計消毒蓋市場在預測期內將以 8.03% 的複合年成長率成長。

消毒蓋可作為防止微生物污染的額外防禦層，以減少與醫療設備相關的疾病發生率。醫療相關感染疾病和癌症患者數量的增加是消毒蓋市場的主要成長動力。此外，對感染控制的日益關注、意識的提高以及產品的推出預計將進一步加強消毒劑瓶蓋市場。

醫療感染疾病(HAI) 盛行率不斷上升

HAI 的流行是消毒蓋市場的主要成長要素。據世界衛生組織稱，每 100 名急診醫院患者中，高所得國家有 7 名患者和中低收入國家有 15 名患者在住院期間至少發生一種醫療保健相關感染 (HAI)。據世界衛生組織稱，預計這些患者中平均有十分之一死於醫院感染。此外，根據 CDC資料，從 2020 年到 2021 年，美國耐甲氧西林金黃色葡萄球菌 (MRSA) 的盛行率增加了 14%，2021 年人工呼吸器相關事件 (VAE) 增加了 12%。

癌症患者增加

消毒帽市場主要是由癌症發病率上升推動的，因為它們被用來清洗靜脈注射連接。例如，根據世界衛生組織的數據，癌症是導致死亡的主要原因，2020 年全球將有超過 1,000 萬人死於癌症。此外，據 WCRF 稱，2020 年全球將診斷出約 1,800 萬名新癌症患者。癌症患者的免疫力可能較弱，因此在癌症治療期間實施適當的感染控制以盡量減少感染疾病風險非常重要。消毒帽是癌症患者的必需品，因為感染疾病使治療和康復過程更加複雜。

醫療保健支出增加

醫療保健支出的成長推動了對先進醫療設備和感染控制產品的需求，從而推動了消毒蓋市場。例如，根據世界衛生組織的報告，由於政府支出和外部援助的增加，2020年全球衛生支出將超過9兆美元。世衛組織報告顯示，世衛組織50個成員國中有超過三分之二的衛生系統管治和管理支出平均增加了7%。隨著醫療保健提供者投資於改善患者治療效果並減少與感染疾病相關的總體成本負擔的產品，消毒蓋市場正受益於此趨勢。

日益重視感染控制

感染控制程序越來越受到醫療機構和監管機構的關注。嚴格的法規和標準已經到位，以提高病人安全並減少醫院感染的發生頻率。政府機構正在組織各種計劃來減少感染疾病和醫院感染，這正在推動消毒蓋市場的發展。例如，新興感染疾病計畫 (EIB) 是由 CDC 與美國農業部和其他 10 個美國機構合作進行的。 EIB 使用被稱為 ABC 的主動實驗室和基於人群的監測系統來監測對公共衛生具有重要意義的侵入性細菌感染。感染預防和控制（IPC）是世界衛生組織制定的一項實用的、基於證據的策略，旨在避免可能傷害患者和相關人員的感染疾病。

市場抑制因素

儘管消毒瓶蓋市場正在不斷成長和開拓，但也存在影響市場擴張的抑制因素和挑戰。例如，醫療保健專業人員和患者對消毒劑瓶蓋的好處和意義的了解有限可能會限制市場擴張。此外，由於市面上的醫療設備種類繁多，因此很難保持消毒蓋的通用相容性。此外，遵守法律規章和獲得必要認證所需的時間和成本可能會減緩消毒市場的成長並限制新的進入。

北美地區預計將大幅成長

預計在預測期內，北美地區將佔據消毒蓋市場的主要佔有率。推動該地區市場成長的因素包括醫院感染數量的增加、強大的醫療保健系統、強力的政府計劃以及對感染負面影響的認知不斷提高。例如，據膿毒症聯盟稱，美國每年有超過 60,000 名嚴重膿毒症患者接受緊急醫療服務治療，這一數字被認為比心臟病和中風患者的總合還多。此外，由於該地區是 3M、B Braun 和 ICU Medical 等主要消毒蓋製造商和經銷商的所在地，預計該市場還將擴大。

主要市場參與者

3M是一家總部位於美國的跨國集團。 3M 提供廣泛的產品、技術和解決方案，旨在改善患者治療效果、感染預防和整體醫療保健效率。這種含酒精的蓋子稱為 3MTM Curos(TM) 無針連接器消毒蓋，可旋入連接埠進行消毒和屏蔽。 ICU Medical 提供各種產品和解決方案，包括輸液系統、靜脈導管、重症加護監護和無針連接器。該公司開發的SwabCap(TM)消毒帽是無菌的，獨立包裝，可在30秒內消毒，有效期長達7天。 Omnia Health 為醫療保健專業人員和供應商提供各種服務和解決方案，包括創新解決方案和諮詢。 iVCAP 由該公司設計，用作拭子魯爾接入閥的蓋子，以保護它們免受潛在污染。 Becton Dickinson 業務遍及醫療保健產業的各個領域，包括醫療機構、生命科學研究和臨床測試。 BD PureHub(TM) 消毒蓋不僅充當管線接入之間的物理屏障，而且還充當在接入之前清洗可擦拭、無針魯爾連接的工具。

新興市場的主要發展

2019年11月，Asset Medical發布了最新產品「SwabArt(R)消毒帽」。這是一種一次性消毒產品，使用浸有 70% IPA 的高吸水性海綿來防止感染。 2019 年 11 月，ICU Medical 宣布以 7,500 萬美元收購 Pursuit Vascular, Inc.，以擴展其無針 IV 連接器和其他感染控制技術。 Pursuit Vascular 的主要產品是 ClearGuard(R) HD 帽，用於維護血液透析機導管。

Disinfectant caps serve as an extra layer of defense against microbial contamination to lower the incidence of illnesses linked to medical equipment. The growing prevalence of healthcare-acquired infections and cancer cases are major growth drivers in the disinfection cap market. Moreover, the increasing emphasis on infection control and rising awareness coupled with enhanced product launches are further expected to bolster the disinfection cap market.

Growing Prevalence of Healthcare-acquired Infections (HAIs)

The growing prevalence of HAIs is a major growth driver of the disinfection cap market. According to the WHO, seven patients in high-income countries and 15 patients in low- and middle-income countries out of every 100 patients in acute-care hospitals acquire at least one healthcare-associated infection (HAI) during their hospital stay. On average, one in ten of these patients is expected to die from their HAI as per the WHO. Moreover, the methicillin-resistant Staphylococcus aureus (MRSA) prevalence rate in the USA increased by 14% in 2021 from 2020 and ventilator-associated events (VAE) increased by 12% in 2021 as per the CDC data.

Increasing Cancer Cases

The disinfection cap market is being driven in large part by the rising incidence of cancer as these are used to clean IV connections. For instance, cancer is the leading death cause with more than 10 million worldwide deaths in 2020 according to the WHO. There were around 18 million new cancer cases worldwide in 2020 as per the WCRF. It is important to maintain proper infection control practices during cancer treatment to minimize the risk of infections, as cancer patients may have compromised immune systems. Infections can further complicate the treatment and recovery process therefore disinfection cap is a necessary component for cancer patients.

Rising Healthcare Expenditure

Increasing healthcare expenditure is driving the demand for advanced medical devices and infection control products thereby propelling the disinfection cap market. For instance, global health spending topped $9 trillion in 2020 owing to increased government spending and external aid as per the WHO report. In more than two-thirds of the 50 WHO nations, spending on health system governance and administration increased by an average of 7%. The disinfection cap market benefits from this trend as healthcare providers invest in products that improve patient outcomes and reduce the overall cost burden associated with infections.

Increased Emphasis on Infection Control

Infection control procedures are receiving more attention from healthcare facilities and regulatory agencies. To enhance patient safety and lower the frequency of HAIs, strict restrictions and standards are being introduced. Various programs are being organized by the government institution to reduce infections and HAIs which is aiding the disinfection cap market. For instance, the Emerging Infections Program (EIB) is being run by CDC in collaboration with the US Department of Agriculture, and 10 other US sites. An active laboratory- and population-based surveillance system called ABCs is used to monitor invasive bacterial infections that are significant for public health and is used by EIB. IPC (infection prevention and control) is a realistic, evidence-based strategy developed by the WHO for avoiding infections that might damage patients and healthcare professionals.

Restraints in the Market

The disinfection cap market has experienced growth and development, however, some restraints or challenges can impact its expansion. For example, healthcare professionals and patients' limited knowledge of the advantages and significance of disinfection caps may restrain market expansion. Moreover, due to the variety of medical equipment in the market, maintaining universal compatibility of disinfection caps might be difficult. Additionally, meeting regulatory compliance and obtaining necessary certifications can be time-consuming and expensive, potentially slowing down the disinfection market growth and limiting the entry of new players.

North America is Expected to Grow Significantly

The North American region is anticipated to hold a significant share of the disinfection cap market during the forecasted period. Various factors propelling the market growth in the region are higher HAIs, the presence of a strong healthcare system, robust government programs, and increased awareness about the adverse effects of infection. For instance, over 60,000 more severe sepsis patients are thought to be treated by emergency medical services in the United States each year than heart attack and stroke patients combined as per the Sepsis Alliance. Moreover, the presence of major producers and distributors of disinfection caps in the region such as 3M, B Braun, and ICU Medical is further expected to aid the market expansion.

Major Market Players

3M is a multinational conglomerate corporation headquartered in the United States. 3M offers a wide array of products, technologies, and solutions aimed at improving patient outcomes, infection prevention, and overall healthcare efficiency. An alcohol-containing cap called the 3MTM Curos™ Disinfecting Cap for Needleless Connectors twists onto ports to disinfect and shield them.
ICU Medical offers a diverse portfolio of products and solutions including infusion systems, IV catheters, critical care monitoring, and needleless connectors. SwabCap™ disinfecting cap developed by the company offers individual sterile packaging and the ability to disinfect within 30 seconds for up to 7 days.
Omnia Health offers various services and solutions to healthcare providers and suppliers including innovative solutions and consultations. I.V. CAPs are designed by the company to be used as a cover over swab-able luer access valves to shield them from potential contamination.
Becton Dickinson operates across various segments of the healthcare industry, including healthcare institutions, life sciences research, and clinical laboratories. In addition to serving as a physical barrier between line accesses, the BD PureHub™ disinfection cap also serves as a tool for cleaning swabbable needle-free luer connections before access.

Key Market Developments

In November 2019, Asset Medical announced its newest product the SwabArt® Disinfection Cap. These are single-use disinfection product that protects from infection through a highly liquid absorbent sponge saturated with 70% of IPA.
In November 2019, ICU Medical announced the acquisition of Pursuit Vascular, Inc for $75 million to expand its needle-free IV connector and other infection control technologies. The primary product of Pursuit Vascular was the ClearGuard® HD cap which is used for the maintenance of hemodialysis catheters.

Segmentation:

By Type

Double Cap System
Single Cap System

By Distributor

Retail
Non-retail

By End-Use

Hospitals
Clinics
Others

By Geography

North America
United States
Canada
Mexico
South America
Brazil
Argentina
Others
Europe
United Kingdom
Germany
France
Spain
Others
Middle East and Africa
Saudi Arabia
UAE
Israel
Others
Asia Pacific
Japan
China
India
South Korea
Indonesia
Thailand
Others

1. INTRODUCTION

1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.4. Market Segmentation
1.5. Currency
1.6. Assumptions
1.7. Base, and Forecast Years Timeline

2. RESEARCH METHODOLOGY

2.1. Research Data
2.2. Assumptions

3. EXECUTIVE SUMMARY

3.1. Research Highlights

4. MARKET DYNAMICS

4.1. Market Drivers
4.2. Market Restraints
4.3. Porter's Five Force Analysis
- 4.3.1. Bargaining Power of Suppliers
- 4.3.2. Bargaining Power of Buyers
- 4.3.3. Threat of New Entrants
- 4.3.4. Threat of Substitutes
- 4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis

5. DISINFECTION CAP MARKET, BY TYPE

5.1. Introduction
5.2. Double Cap System
5.3. Single Cap System

6. DISINFECTION CAP MARKET, BY DISTRIBUTOR

6.1. Introduction
6.2. Retail
6.3. Non-retail

7. DISINFECTION CAP MARKET, BY END-USE

7.1. Introduction
7.2. Hospitals
7.3. Clinics
7.4. Others

8. DISINFECTION CAP MARKET, BY GEOGRAPHY

8.1. Introduction
8.2. North America
- 8.2.1. United States
- 8.2.2. Canada
- 8.2.3. Mexico
8.3. South America
- 8.3.1. Brazil
- 8.3.2. Argentina
- 8.3.3. Others
8.4. Europe
- 8.4.1. United Kingdom
- 8.4.2. Germany
- 8.4.3. France
- 8.4.4. Spain
- 8.4.5. Others
8.5. The Middle East and Africa
- 8.5.1. Saudi Arabia
- 8.5.2. UAE
- 8.5.3. Israel
- 8.5.4. Others
8.6. Asia Pacific
- 8.6.1. Japan
- 8.6.2. China
- 8.6.3. India
- 8.6.4. South Korea
- 8.6.5. Indonesia
- 8.6.6. Thailand
- 8.6.7. Others